Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Not applicableLooking for participantsNCT06208137
What this trial is testing

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 456
Testing effectiveness (Phase 2)UnknownNCT00749164
What this trial is testing

Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment

Who this might be right for
Graft-Versus-Host Disease
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24
Not applicableEnded earlyNCT03080792
What this trial is testing

Pre-Exercise for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Cancer, Hematological
University Hospital Heidelberg 14
Testing effectiveness (Phase 2)Study completedNCT04466007
What this trial is testing

Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia

Who this might be right for
Limb IschemiaDiabetic Foot
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 90
Early research (Phase 1)Ended earlyNCT03588936
What this trial is testing

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Who this might be right for
Acute LeukemiaChronic LeukemiaLymphoma+1 more
Medical College of Wisconsin 2
Testing effectiveness (Phase 2)UnknownNCT05914714
What this trial is testing

Ruxolitinib as GVHD Prophylaxis in AA Patients

Who this might be right for
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
Institute of Hematology & Blood Diseases Hospital, China 46
Large-scale testing (Phase 3)Ended earlyNCT05170009
What this trial is testing

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

Who this might be right for
Influenza
Weill Medical College of Cornell University 2
Early research (Phase 1)Ended earlyNCT00943293
What this trial is testing

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Who this might be right for
PreleukemiaMyeloproliferative DisordersLymphoma+2 more
University of Chicago 1
Not applicableNot Yet RecruitingNCT07782138
What this trial is testing

A Single-Center Clinical Study Evaluating the Efficacy and Safety of Allogeneic Natural Killer (NK) Cell Transplantation for Mooren's Ulcer

Who this might be right for
Cornea Disease
Suxia Li 6
Not applicableUnknownNCT03659084
What this trial is testing

Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Hospices Civils de Lyon 150
Testing effectiveness (Phase 2)Study completedNCT05090384
What this trial is testing

Pediatric GVHD Low Risk Steroid Taper Trial

Who this might be right for
Acute Graft vs Host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects
John Levine 50
Not applicableNot Yet RecruitingNCT06758726
What this trial is testing

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)UnknownNCT03384433
What this trial is testing

Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke

Who this might be right for
Cerebrovascular Disorders
Isfahan University of Medical Sciences 5
Early research (Phase 1)Active Not RecruitingNCT04098393
What this trial is testing

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT04167514
What this trial is testing

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Who this might be right for
Graft Versus Host Disease (GVHD)
CSL Behring 136
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT04716998
What this trial is testing

Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19

Who this might be right for
Covid19
BonusBio Group Ltd 50
Next Page